Editorial: Bispecific Antibodies for T-Cell Based Immunotherapy

Editorial: Bispecific Antibodies for T-Cell Based Immunotherapy

Bibliographic Details
Main Authors:	Brian H. Santich, Nai-Kong V. Cheung, Christian Klein
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2020-12-01
Series:	Frontiers in Oncology
Subjects:	bispecific antibody T-cell immunotherapy protein engineering oncology
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2020.628005/full

Similar Items

Bispecific Antibodies: A Smart Arsenal for Cancer Immunotherapies
by: Gihoon You, et al.
Published: (2021-07-01)

Cancer Immunotherapy by Retargeting of Immune Effector Cells via Recombinant Bispecific Antibody Constructs
by: Slava Stamova, et al.
Published: (2012-07-01)

Immunotherapy with Antibodies in Multiple Myeloma: Monoclonals, Bispecifics, and Immunoconjugates
by: Christie P. M. Verkleij, et al.
Published: (2021-03-01)

Bispecific antibodies and their use in applied research
by: Harshit Verma, et al.
Published: (2012-01-01)

Drug Conjugated and Bispecific Antibodies for Multiple Myeloma: Improving Immunotherapies off the Shelf
by: Gregorio Barilà, et al.
Published: (2021-01-01)

Research and Clinical Landscape of Bispecific Antibodies for the Treatment of Solid Malignancies
by: Gabriele Antonarelli, et al.
Published: (2021-08-01)

A Bispecific Antibody to Link a TRAIL-Based Antitumor Approach to Immunotherapy
by: Alessandro Satta, et al.
Published: (2019-10-01)

Taking up Cancer Immunotherapy Challenges: Bispecific Antibodies, the Path Forward?
by: Joanie Del Bano, et al.
Published: (2015-12-01)

Bispecific antibody does not induce T-cell death mediated by chimeric antigen receptor against disialoganglioside GD2
by: Sayed Shahabuddin Hoseini, et al.
Published: (2017-06-01)

Overcoming resistance to HER2-targeted therapy with a novel HER2/CD3 bispecific antibody
by: Andres Lopez-Albaitero, et al.
Published: (2017-03-01)

Modulating tumor infiltrating myeloid cells to enhance bispecific antibody-driven T cell infiltration and anti-tumor response
by: Jeong A. Park, et al.
Published: (2021-09-01)

GD2 or HER2 targeting T cell engaging bispecific antibodies to treat osteosarcoma
by: Jeong A. Park, et al.
Published: (2020-12-01)

Bispecific T cell engagers: an emerging therapy for management of hematologic malignancies
by: Zheng Tian, et al.
Published: (2021-05-01)

Discovery Strategies to Maximize the Clinical Potential of T-Cell Engaging Antibodies for the Treatment of Solid Tumors
by: Vladimir Voynov, et al.
Published: (2020-11-01)

Immunotherapy of B-Cell Lymphoma with an Engineered Bispecific Antibody Targeting CD19 and CD5
by: Frank Breitling, et al.
Published: (2013-05-01)

Combination of T-Cell Bispecific Antibodies With PD-L1 Checkpoint Inhibition Elicits Superior Anti-Tumor Activity
by: Johannes Sam, et al.
Published: (2020-11-01)

In Situ Liver Expression of HBsAg/CD3-Bispecific Antibodies for HBV Immunotherapy
by: Robert L. Kruse, et al.
Published: (2017-12-01)

Bispecific Antibodies: A New Era of Treatment for Multiple Myeloma
by: Xiang Zhou, et al.
Published: (2020-07-01)

Producing and prospects for the use of bispecific antibodies for the treatment of cancer
by: S. E. Sedykh, et al.
Published: (2019-01-01)

Corrigendum: Combination of T-Cell Bispecific Antibodies With PD-L1 Checkpoint Inhibition Elicits Superior Anti-Tumor Activity
by: Johannes Sam, et al.
Published: (2021-02-01)

Potential Role of CD47-Directed Bispecific Antibodies in Cancer Immunotherapy
by: Yan Yang, et al.
Published: (2021-07-01)

Therapeutic Bispecific T-Cell Engager Antibody Targeting the Transferrin Receptor
by: Mingpeng Fu, et al.
Published: (2019-06-01)

ATTACK, a novel bispecific T cell-recruiting antibody with trivalent EGFR binding and monovalent CD3 binding for cancer immunotherapy
by: Seandean Lykke Harwood, et al.
Published: (2018-01-01)

Bispecific antibodies: design, therapy, perspectives
by: Sedykh SE, et al.
Published: (2018-01-01)

Format and geometries matter: Structure-based design defines the functionality of bispecific antibodies
by: Steffen Dickopf, et al.
Published: (2020-01-01)

Bispecific, T-Cell-Recruiting Antibodies in B-Cell Malignancies
by: Margaux Lejeune, et al.
Published: (2020-05-01)

Bispecific Antibodies as a Development Platform for New Concepts and Treatment Strategies
by: Fa Yang, et al.
Published: (2016-12-01)

CD18 Antibody Application Blocks Unwanted Off-Target T Cell Activation Caused by Bispecific Antibodies
by: Joseph Kauer, et al.
Published: (2021-09-01)

An IgG‐based bispecific antibody for improved dual targeting in PSMA‐positive cancer
by: Latifa Zekri, et al.
Published: (2021-02-01)

Generation of dual specific bivalent BiTEs (dbBIspecific T-cell engaging antibodies) for cellular immunotherapy
by: Maciej Kujawski, et al.
Published: (2019-09-01)

A novel bispecific antibody for EGFR-directed blockade of the PD-1/PD-L1 immune checkpoint
by: Iris Koopmans, et al.
Published: (2018-08-01)

A CLDN18.2-Targeting Bispecific T Cell Co-Stimulatory Activator for Cancer Immunotherapy
by: Liang J, et al.
Published: (2021-09-01)

Clinical and immune responses to anti-CD3 x anti-EGFR bispecific antibody armed activated T cells (EGFR BATs) in pancreatic cancer patients
by: Lawrence G. Lum, et al.
Published: (2020-01-01)

Engineering Immune Cells for in vivo Secretion of Tumor-Specific T Cell-Redirecting Bispecific Antibodies
by: Belén Blanco, et al.
Published: (2020-08-01)

A Novel Anti-HER2 Bispecific Antibody With Potent Tumor Inhibitory Effects In Vitro and In Vivo
by: Mehdi Mohammadi, et al.
Published: (2021-02-01)

The development of bispecific antibodies and their applications in tumor immune escape
by: Xiaolong Zhang, et al.
Published: (2017-05-01)

The landscape of bispecific T cell engager in cancer treatment
by: Shujie Zhou, et al.
Published: (2021-05-01)

Overcoming Challenges for CD3-Bispecific Antibody Therapy in Solid Tumors
by: Jim Middelburg, et al.
Published: (2021-01-01)

Bispecific Antibodies and Antibody–Drug Conjugates for Cancer Therapy: Technological Considerations
by: Hyunbo Shim
Published: (2020-02-01)

Development of a Bispecific Antibody Targeting CD30 and CD137 on Hodgkin and Reed-Sternberg Cells
by: Sakthi Rajendran, et al.
Published: (2019-09-01)